triazolam has been researched along with Diplopia in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Diplopia: A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The peak concentration was 4." | 2.70 | Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients. ( Coldwell, SE; Kaakko, T; Kharasch, ED; Milgrom, P; Spieker, M; Tweedy, CM, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tweedy, CM | 1 |
| Milgrom, P | 1 |
| Kharasch, ED | 1 |
| Kaakko, T | 1 |
| Spieker, M | 1 |
| Coldwell, SE | 1 |
1 trial available for triazolam and Diplopia
| Article | Year |
|---|---|
Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients.
Topics: Administration, Sublingual; Amnesia; Anti-Anxiety Agents; Area Under Curve; Ataxia; Child; Child, Pr | 2001 |